(19)
(11) EP 3 060 220 A1

(12)

(43) Date of publication:
31.08.2016 Bulletin 2016/35

(21) Application number: 14856165.7

(22) Date of filing: 08.08.2014
(51) International Patent Classification (IPC): 
A61K 31/663(2006.01)
A61P 19/02(2006.01)
A61K 9/52(2006.01)
A61P 29/00(2006.01)
(86) International application number:
PCT/US2014/050427
(87) International publication number:
WO 2015/060924 (30.04.2015 Gazette 2015/17)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 25.10.2013 US 201314063979
15.05.2014 US 201414279241

(71) Applicant: Antecip Bioventures II LLC
New York, NY 10111 (US)

(72) Inventor:
  • TABUTEAU, Herriot
    New York, New York 10111 (US)

(74) Representative: Green, Mark Charles 
Urquhart-Dykes & Lord LLP The Podium 1 Eversholt Street
London NW1 2DN
London NW1 2DN (GB)

   


(54) COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE